Ritter Pharmaceuticals, Inc.
(NASDAQ : RTTR)

( )
RTTR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
2.54%20.632.0%$670.00m
SHPGShire PLC Sponsored ADR
1.05%177.360.4%$150.56m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.16%147.236.8%$143.10m
PRGOPerrigo Co. Plc
1.57%73.896.8%$102.73m
JAZZJazz Pharmaceuticals Plc
0.62%158.862.2%$69.53m
ENDPEndo International Plc
-6.83%17.058.9%$65.30m
MNKMallinckrodt Plc
-1.37%27.4521.1%$57.23m
ICPTIntercept Pharmaceuticals, Inc.
-2.69%104.7318.7%$50.43m
SAGESAGE Therapeutics, Inc.
-2.44%121.449.6%$47.96m
UTHRUnited Therapeutics Corporation
-0.03%127.0014.4%$38.29m
CTLTCatalent Inc
1.14%43.372.4%$34.11m
ICLRICON Plc
-1.33%147.174.1%$33.64m
AERIAerie Pharmaceuticals, Inc.
1.45%60.046.9%$29.76m
PTLAPortola Pharmaceuticals, Inc.
2.96%23.677.7%$29.29m
MDCOMedicines Company
-1.14%27.7721.8%$28.07m

Company Profile

Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J. Ritter and Ira E. Ritter on March 29, 2004 and is headquartered in Los Angeles, CA.